台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中化生

(1762)
可現股當沖
  • 股價
    33.05
  • 漲跌
    ▼0.15
  • 漲幅
    -0.45%
  • 成交量
    77
  • 產業
    上市 生技醫療類股
  • 250人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中化生 (1762)籌碼相關-群益金鼎-瑞豐 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-瑞豐 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/140.133.0000.0033.150.11190.04%
2025/01/13233.25133.4033.1511180.84%
2025/01/0800.00134.0534.70-1110-0.90%
2025/01/03133.6000.0033.4011040.95%
2024/12/30134.3000.0034.1511060.94%
2024/11/200.138.6000.0038.400.11010.05%
2024/09/042.141.4600.0041.202.13250.63%
2024/08/15244.3000.0044.1523330.60%
2024/08/120.143.1000.0043.700.13390.03%
2024/08/070.146.9500.0046.800.13230.02%
2024/08/060.146.5000.0047.400.13190.02%
2024/08/05147.6000.0047.4013120.32%
2024/07/1100.000.353.0053.00-0.3276-0.09%
2024/07/0400.00551.1051.50-5275-1.82%
2024/06/2700.00252.5052.20-2278-0.72%
2024/06/2400.00150.9050.70-1257-0.39%
2024/06/1800.00150.3049.90-1253-0.39%
2024/06/1400.00248.7548.80-2253-0.79%
2024/06/13148.45148.5048.4002540.00%
2024/06/1100.00149.5048.65-1245-0.41%
2024/06/03048.4000.0048.4502610.00%
2024/05/21146.8500.0046.8512750.36%
2024/05/20547.60148.0047.5042751.45%
2024/05/1000.00147.3047.30-1285-0.35%
2024/04/30046.1000.0046.1502890.00%
2024/04/191.144.7800.0043.801.13090.34%
2024/04/1800.00445.2045.70-4308-1.30%
2024/04/17445.5500.0045.5543141.27%
2024/04/15146.1500.0046.1513200.31%
2024/04/120.147.5000.0047.150.13130.02%
2024/04/03247.7000.0047.6023010.66%
2024/03/2900.00348.8548.85-3289-1.04%
2024/03/26050.4000.0049.1002850.00%
2024/03/20350.3700.0050.2032841.05%
2024/03/19049.50549.3649.25-5280-1.78%
2024/03/18049.1500.0049.2002820.00%
2024/03/13548.6000.0048.5052871.74%
2024/03/1200.00150.1049.70-1288-0.35%
2024/03/08148.3000.0048.3012950.34%
2024/03/0700.00149.0049.30-1307-0.33%
2024/03/06150.0000.0049.7513160.32%
2024/03/04049.9000.0049.6003290.00%
2024/02/210.150.6000.0050.700.14360.02%
2024/02/200.150.2000.0050.100.14370.02%
2024/02/15149.9000.0049.8514390.23%
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章